Wall Street

Online Stock Market Trading By Staff

Burned by Leila's betrayal, Cassie must forge ahead alone, driven to beat her partner turned rival to the streets.

Stock Investing Course (EUNN)London - German drug-maker, Merck KGaA, plans to make a hostile bid of $17.7 billion on Monday for Schering A.G. (NYSE; SHR), its German rival. The two German drug makers are not connected to the US drug companies with similar names.

Based on evidence showing increased heart attack rates in Vioxx users, the FDA suggested putting a cardiovascular warning on the label. Merck, the maker of Vioxx, vehemently objected. On November 8, 2001, when talks with the FDA were not going to Merck%š liking, the head of Merck%š

Stock Market Game It was Schering A.G. who disclosed the hostile bid plan. The world's largest manufacturer of contraceptive drugs said it intended on rejecting Merck's bid.

AG hereby grants to Participant, for the Term of this Agreement, exclusive, transferable, revocable license to use the AG Intellectual Property contained in the Integrations, subject to AG's approval, for the sole purpose of performing its obligations under this Agreement. You do not have the right to change, alter, edit, or modify the AG Intellectual Property in any way. You, by virtue of this Agreement, shall not obtain or claim any right, title or interest in or to the AG Intellectual Property, except the right of use as specified herein, and you acknowledge and agree that all such use shall inure to the benefit of AG.

Stock Investing Game Merck KGaA is expected to offer 77 euros per share, Schering said.

AG hereby grants to Participant, for the Term of this Agreement, exclusive, transferable, revocable license to use the AG Intellectual Property contained in the Integrations, subject to AG's approval, for the sole purpose of performing its obligations under this Agreement. You do not have the right to change, alter, edit, or modify the AG Intellectual Property in any way. You, by virtue of this Agreement, shall not obtain or claim any right, title or interest in or to the AG Intellectual Property, except the right of use as specified herein, and you acknowledge and agree that all such use shall inure to the benefit of AG.

Journal Prime Rate Street Wall Schering stated that the offer "significantly undervalues Schering and its prospects as an independent specialized pharmaceutical company."

- - Best Buy's powerful showing this spring was something of a surprise. Wall Street will gain a little more insight into how the consumer electronics industry is faring Friday when Best Buy rival Circuit City Stores Inc. reports its quarterly fiscal earnings.

Stock Market News Merck officials informed Schering over the weekend that it intended to make a formal offer on Monday. Merck has not commented on its plans to buy Schering.

Stock Investing Basics Schering reported a 17 percent jump in net income in the fourth quarter, to 139 million euros. The German oral contraceptive maker attributed the rise in earnings to both its birth control and multiple sclerosis product sales. Schering is considered a a strong takeover target in the pharmaceutical industry.

Stock Investing Software Merck produces the cancer drug Erbitux as well as generic drugs, chemicals like paint pigments and liquid crystal displays used in television. Its full-year profit for 2005 was almost even with that the year before, at about $800 million.

Stock Market Trading If Merck were successful in buying Schering it would create the second-largest drug maker in Germany behind Bayer A.G., which reported 11 billion euros in sales last year.

Stock Investing For Dummy Merck's offer is a 15 percent premium to Friday's closing price, though Schering says its undervalued at that price. In support of that statement, Schering had disclosed in February that it intended to buy back 500 million euros worth of its shares off the open market between March and September.

Stock Market Crash German business journal, Manager-Magazin, reported that the Merck family, which controls 73 percent of Merck's stock, intended on selling 20 percent of its holdings and adding 2 billion euros in cash to finance the deal.

Stock Investing Tip Merck is the world's oldest pharmaceutical company. The larger Merck & Company, based in Whitehouse Station, N.J., was once a subsidiary of Merck KGaA, but became independent after World War I.

Stock Market Chart Schering and the American drug maker Schering-Plough were both founded by Ernst Schering, a German pharmacist, in the 19th century, and have long been separate companies for decades.

[ Comment, Edit or Article Submission ]